Amarin (AMRN)
(Delayed Data from NSDQ)
$0.86 USD
-0.11 (-11.51%)
Updated May 8, 2024 04:00 PM ET
3-Hold of 5 3
D Value C Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 34% (86 out of 250)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 3.50 | 1.35 | 9.99 |
Current Quarter Estimate | -0.05 | 7.43 | 57.00 |
Year Ago Quarter Estimate | 0.02 | 0.12 | 52.54 |
Next Quarter Estimate | -0.06 | 7.81 | 61.00 |
Next Year Estimate | -0.19 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -666.67 | 13.30 | 15.67 |
Next Year | -11.76 | 8.10 | 9.31 |
Last 5 Years | NA | 1.00 | 8.10 |
Next 5 Years | NA | 20.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 86.29 | -2.18 |
Price/Book (MRQ) | 0.65 | 2.14 |
Price/Cash Flow (MRFY) | NA | 15.07 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -18.96% | -15.18% |
Return on Equity (TTM) | -9.48% | -19.32% |
Debt to Equity (MRQ) | 0.00 | 1.82 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.